25.8 C
Sunday, June 16, 2024

Benedikt Pelzer, MD

Home » Benedikt Pelzer, MD Researcher Spotlight: Benedikt Pelzer, MD WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY The Levine Family Fellowship Marginal zone lymphoma (MZL) is a slow-growing type of cancer that can eventually transform into a more aggressive diffuse B-cell lymphoma (DLBCL) in a subset of patients. Both MZL and DLBCL are characterized by a high frequency of...

Atish Kizhakeyil, PhD

Home » Atish Kizhakeyil, PhD Researcher Spotlight: Atish Kizhakeyil, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Alterations in the DTX1 gene are highly prevalent in diffuse large B-cell lymphoma (DLBCL), but their clinical significance remains unclear. Using animal models and advanced genomic technologies, Dr. Kizhakeyil’s research is focused on characterizing these changes to better understand how...

Ruth Alonso-Alonso, PhD

Home » Ruth Alonso-Alonso, PhD Researcher Spotlight: Ruth Alonso-Alonso, PhD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Oliver W. Press, MD, PhD Memorial Fellow Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive form of peripheral T-cell lymphoma. Therapeutic options for AITL are limited given patients’ poor responses to conventional chemotherapy, resulting in poor outcomes and...

West Coast Lymphoma Workshop: September 14, 2024 – Marina Del Rey, CA

Home » West Coast Lymphoma Workshop: September 14, 2024 – Marina Del Rey, CA West Coast Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options DATE: Saturday, September 14, 2024TIME:  8:15 AM PT – 1:30 PM PT LOCATION: Marina Del Rey Marriott4100 Admiralty WayMarina Del Rey, CA 90292 Parking: Check back near date of program. About The Workshop The Lymphoma...

National Lymphoma Workshop: March 16, 2024 – Virtual – Archived

Home » National Lymphoma Workshop: March 16, 2024 – Virtual – Archived The Lymphoma Research Foundation’s Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community across the United States. The National Lymphoma Workshop is the premier patient education and networking forum in the region. For...

Erin Parry, MD, PhD

Researcher Spotlight Home » Erin Parry, MD, PhD Researcher Spotlight: Erin Parry, MD, PhD DANA-FARBER CANCER INSTITUTE Dr. Parry’s research is centered at the intersection of genomics and cancer immunotherapy, with a focus on B cell lymphomas. Her LRF research project is aimed at understanding...

Wen-Hsuan Wendy Lin, MD, PhD

Researcher Spotlight Home » Wen-Hsuan Wendy Lin, MD, PhD Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD COLUMBIA UNIVERSITY Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in...

Timothy Voorhees, MD

Researcher Spotlight Home » Timothy Voorhees, MD Researcher Spotlight: Timothy Voorhees, MD THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE Schroder Family Scholar Post-transplant lymphoproliferative disorders (PTLD) are an aggressive group of lymphomas that occur in the setting of immunosuppression after solid organ transplant. There are very...

Ayushi Chauhan, MD

Researcher Spotlight Home » Ayushi Chauhan, MD Researcher Spotlight: Ayushi Chauhan, MD AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. Stephanie A. Gregory Distinguished Scholar Primary central nervous system lymphoma, or PCNSL, is a rare and aggressive form of non-Hodgkin lymphoma that predominantly affects older adults over the age...

Edward Dominguez, PhD

Researcher Spotlight Home » Edward Dominguez, PhD Researcher Spotlight: Edward Dominguez, PhD BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE HEALTH EQUITY INITIATIVE Cyclin-dependent kinases, including CDK9, are responsible for regulation of a variety of cellular processes that contribute to the growth and expansion of cancer cells....

Time Management Tips


clear sky
25.8 ° C
27 °
22.5 °
55 %
1 %
31 °
34 °
34 °
34 °
30 °

Must Read